The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review

Ahmed B. Bayoumy,Melek Simsek,Margien L. Seinen,Chris J. J. Mulder,Azhar Ansari,Godefridus J. Peters,Nanne K.H. de Boer

The continuous rediscovery and the benefit–risk ratio of thioguanine, a comprehensive review

2020

Ahmed B. Bayoumy
Melek Simsek
Margien L. Seinen
Chris J. J. Mulder
Azhar Ansari
Godefridus J. Peters
Nanne K.H. de Boer

ABSTRACTIntroduction: In the 1950s, thioguanine (TG), a thiopurine-derivative together with azathioprine (AZA) and mercaptopurine (MP), were developed for the treatment of childhood leukemia. Over ...

Keywords:

Rheumatology
Pharmacology
Relative risk
Azathioprine
Inflammatory bowel disease
Childhood leukemia
Internal medicine
Medicine
Mercaptopurine
Diabetes mellitus
Hematology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

123

References

Citations